224 related articles for article (PubMed ID: 36965552)
1. Advances in aptamer-mediated targeted delivery system for cancer treatment.
He S; Du Y; Tao H; Duan H
Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
[TBL] [Abstract][Full Text] [Related]
2. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
3. Aptamer as a targeted approach towards treatment of breast cancer.
Bisht A; Bhowmik S; Patel P; Gupta GD; Kurmi BD
J Drug Target; 2024 Jun; 32(5):510-528. PubMed ID: 38512151
[TBL] [Abstract][Full Text] [Related]
4. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
Sivakumar P; Kim S; Kang HC; Shim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
6. Current progress on aptamer-targeted oligonucleotide therapeutics.
Dassie JP; Giangrande PH
Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
[TBL] [Abstract][Full Text] [Related]
8. Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles.
Zununi Vahed S; Fathi N; Samiei M; Maleki Dizaj S; Sharifi S
J Drug Target; 2019 Mar; 27(3):292-299. PubMed ID: 29929413
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted drug delivery with aptamers.
Zhang Y; Hong H; Cai W
Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687
[TBL] [Abstract][Full Text] [Related]
10. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
[TBL] [Abstract][Full Text] [Related]
11. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y
Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183
[TBL] [Abstract][Full Text] [Related]
13. Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery.
Gilboa E; Berezhnoy A; Schrand B
Cancer Immunol Res; 2015 Nov; 3(11):1195-200. PubMed ID: 26541880
[TBL] [Abstract][Full Text] [Related]
14. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
[TBL] [Abstract][Full Text] [Related]
15. Advances in the development of aptamer drug conjugates for targeted drug delivery.
Chen K; Liu B; Yu B; Zhong W; Lu Y; Zhang J; Liao J; Liu J; Pu Y; Qiu L; Zhang L; Liu H; Tan W
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27800663
[TBL] [Abstract][Full Text] [Related]
16. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
[TBL] [Abstract][Full Text] [Related]
18. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
19. Aptamers used for biosensors and targeted therapy.
Ning Y; Hu J; Lu F
Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects.
Kruspe S; Giangrande PH
Biomedicines; 2017 Aug; 5(3):. PubMed ID: 28792479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
